InnovAge Holding (InnovAge Holding) Forward Dividend Yield % : 0.00% (As of May. 23, 2024)

View and export this data going back to 2021. Start your Free Trial

What is InnovAge Holding Forward Dividend Yield %?

As of today (2024-05-23), the Forward Annual Dividend Yield of InnovAge Holding is 0.00%.

As of today (2024-05-23), the Trailing Annual Dividend Yield of InnovAge Holding is 0.00%.

INNV's Forward Dividend Yield % is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 2.345
* Ranked among companies with meaningful Forward Dividend Yield % only.

InnovAge Holding's Dividends per Share for the three months ended in Mar. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of InnovAge Holding's Forward Dividend Yield %

For the Medical Care Facilities subindustry, InnovAge Holding's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InnovAge Holding's Forward Dividend Yield % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, InnovAge Holding's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where InnovAge Holding's Forward Dividend Yield % falls into.

InnovAge Holding Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

InnovAge Holding (NAS:INNV) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

InnovAge Holding Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of InnovAge Holding's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

InnovAge Holding (InnovAge Holding) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » InnovAge Holding Corp (NAS:INNV) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

8950 East Lowry Boulevard, Denver, CO, USA, 80230

Website

https://www.innovage.com

InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.

Executives

Teresa Sparks	director	40 BURTON HILLS BOULEVARD SUITE 500, NASHVILLE TN 37215
Nicole Damato	officer: CHIEF LEGAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Benjamin C Adams	officer: CHIEF FINANCIAL OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patricia Fontneau	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Christine Bent	officer: CHIEF OPERATIONS OFFICER	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Thomas Scully	director	320 PARK AVENUE, SUITE # 2500, NEW YORK NM 10022
Richard Feifer	officer: CHIEF MEDICAL OFFICER	C/O GENESIS HEALTHCARE, INC., 101 EAST STATE STREET, KENNETT SQUARE PA 19348
James G Carlson	director	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Patrick T Blair	officer: PRESIDENT	8950 E. LOWRY BOULEVARD, DENVER CO 80230
Caroline Dechert	director	580 CALIFORNIA ST., SUITE 1700, SAN FRANCISCO CA 94104
Pavithra Mahesh	director	601 LEXINGTON AVE., 53RD FLOOR, NEW YORK NY 10022
Maureen Hewitt	director, officer: CEO, President and Director	8950 E. LOWRY BLVD., DENVER CO 80230
Maria Lozzano	officer: CORPORATE COO	8950 E. LOWRY BLVD., DENVER CO 80230
Robin Doerr	officer: CHIEF SALES AND MKTG. OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230
Melissa Welch	officer: CHIEF MEDICAL OFFICER	8950 E. LOWRY BLVD., DENVER CO 80230